To include your compound in the COVID-19 Resource Center, submit it here.

FDA panel recommends lifting SCID holds

FDA's Biological Response Modifiers Committee on Thursday recommended lifting last week's holds

Read the full 127 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE